Your best choice depends on your symptoms
#GLP1 #WeightLossDrugs #FDAUpdate #BiohackYourself #PharmacySafety #OzempicWarnings #GreenList #HealthNews #DrugSafety #WegovyNews Disclaimer: This content is for educational and entertainment purposes only, not a substitute for medical advice
373 PRESENCE OF METABOLIC COMORBIDITIES INCREASES THE RISK OF HEPATOCELLULAR CARCINOMA IN SUB-SAHARAN AFRICAN INDIVIDUALS LIVING WITH CHRONIC HEPATITIS B Lesley Patmore 1 Kirsi van Eekhout 2 Maria Buti 3 zgr Muhammet Koc 4 Kosh Agarwal 5 Robert De Knegt 1 Harry Janssen 1 Marc van der Valk 2 Faydra Lieveld 6 Matthijs Kramer 7 Joep de Bruijne 6 Mark Claassen 8 Colette Smit 9 Robert De Man 10 Bart Takkenberg 11 Ivana Carey 5 Milan Sonneveld 10 , 1 Erasmus MC, 2 Amsterdam UMC, 3 Hospital Valle Hebron, 4 Maastricht UMC+, 5 King's college Hospital, 6 UMC utrecht, 7 Maastricht UMC, 8 Rijnstate Hospital, 9 HIV monitoring Foundation Amsterdam, 10 Erasmus University Medical Center, 11 Amsterdam University Medical Centers, location AMC Background: Recent studies have identified metabolic comorbidities (MC) as risk factors for hepatocellular carcinoma (HCC) in individuals with chronic hepatitis B (CHB)
The authors found that exposure to -PGN led to increased intestinal permeability of PEG-900 in Guinea pigs and also caused substantial ulceration of the caecum
(SEMALCO)
